<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We examined the impact of <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:mp ids='MP_0002959'>microalbuminuria</z:mp> on insulin sensitivity in patients with Type 2 (non-insulin-dependent) <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> using the euglycaemic insulin clamp technique in 52 Type 2 diabetic patients and in 19 healthy control subjects </plain></SENT>
<SENT sid="1" pm="."><plain>Twenty-five diabetic patients had <z:hpo ids='HP_0000822'>hypertension</z:hpo> and 19 had <z:mp ids='MP_0002959'>microalbuminuria</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000822'>Hypertension</z:hpo> per se was associated with a 27% reduction in the rate of total <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism and a 40% reduction in the rate of non-oxidative <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism compared with normotensive Type 2 diabetic patients (both p &lt; 0.001) </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi> metabolism was also impaired in normotensive microalbuminuric patients compared with normotensive normoalbuminuric patients (29.4 +/- 2.2 vs 40.5 +/- 2.8 mumol.kg lean body mass-1.min-1; p = 0.012), primarily due to a reduction in non-oxidative <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism (12.7 +/- 2.9 vs 21.1 +/- 2.6 mumol.kg lean body mass-1.min-1; p = 0.06) </plain></SENT>
<SENT sid="4" pm="."><plain>In a factorial ANOVA design, however, only <z:hpo ids='HP_0000822'>hypertension</z:hpo> (p = 0.008) and the combination of <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:mp ids='MP_0002959'>microalbuminuria</z:mp> (p = 0.030) were significantly associated with the rate of <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism </plain></SENT>
<SENT sid="5" pm="."><plain>The highest <z:chebi fb="0" ids="17855">triglyceride</z:chebi> and lowest <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> concentrations were observed in Type 2 diabetic patients with both <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:mp ids='MP_0002959'>microalbuminuria</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Of note, <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism was indistinguishable from that in control subjects in Type 2 diabetic patients without <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:mp ids='MP_0002959'>microalbuminuria</z:mp> (40.5 +/- 2.8 vs 44.4 +/- 2.8 mumol.kg lean body mass-1.min-1) </plain></SENT>
<SENT sid="7" pm="."><plain>We conclude that <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is predominantly associated with either <z:hpo ids='HP_0000822'>hypertension</z:hpo> or <z:mp ids='MP_0002959'>microalbuminuria</z:mp> or with both </plain></SENT>
</text></document>